These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 29618366)
1. Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome - new data and literature review. Pittaway JFH; Harrison C; Rhee Y; Holder-Espinasse M; Fryer AE; Cundy T; Drake WM; Irving MD Orphanet J Rare Dis; 2018 Apr; 13(1):47. PubMed ID: 29618366 [TBL] [Abstract][Full Text] [Related]
2. Hajdu-Cheney Syndrome, a Disease Associated with NOTCH2 Mutations. Canalis E; Zanotti S Curr Osteoporos Rep; 2016 Aug; 14(4):126-31. PubMed ID: 27241678 [TBL] [Abstract][Full Text] [Related]
3. Exploratory use of romosozumab for osteoporosis in a patient with Hajdu-Cheney syndrome: a case report. Kim KJ; Hong N; Lee S; Shin S; Rhee Y Osteoporos Int; 2023 May; 34(5):1005-1009. PubMed ID: 36622389 [TBL] [Abstract][Full Text] [Related]
4. Severe osteoporosis and mutation in NOTCH2 gene in a woman with Hajdu-Cheney syndrome. Stathopoulos IP; Trovas G; Lampropoulou-Adamidou K; Koromila T; Kollia P; Papaioannou NA; Lyritis G Bone; 2013 Jan; 52(1):366-71. PubMed ID: 23117206 [TBL] [Abstract][Full Text] [Related]
5. The Age Dependent Progression of Hajdu-Cheney Syndrome in Two Families. Jirečková J; Magner M; Lambert L; Baxová A; Leiská A; Kopečková L; Fajkusová L; Zeman J Prague Med Rep; 2018; 119(4):156-164. PubMed ID: 30779700 [TBL] [Abstract][Full Text] [Related]
6. Integrated anti-remodeling and anabolic therapy for the osteoporosis of Hajdu-Cheney syndrome. McKiernan FE Osteoporos Int; 2007 Feb; 18(2):245-9. PubMed ID: 17103298 [TBL] [Abstract][Full Text] [Related]
7. Effect of zoledronic acid on acro-osteolysis and osteoporosis in a patient with Hajdu-Cheney syndrome. Hwang S; Shin DY; Moon SH; Lee EJ; Lim SK; Kim OH; Rhee Y Yonsei Med J; 2011 May; 52(3):543-6. PubMed ID: 21488202 [TBL] [Abstract][Full Text] [Related]
8. Distinct severity of phenotype in Hajdu-Cheney syndrome: a case report and literature review. Zeng C; Lin Y; Lu Z; Chen Z; Jiang X; Mao X; Liu Z; Lu X; Zhang K; Yu Q; Wang X; Huang Y; Liu L BMC Musculoskelet Disord; 2020 Mar; 21(1):154. PubMed ID: 32143606 [TBL] [Abstract][Full Text] [Related]
9. First case of Hajdu-Cheney syndrome in Lithuania caused by novel NOTCH2 gene likely pathogenic variant. Tėvelytė I; Bertašius P; Aleknavičienė K; Jonikas R; Klimaitė J; Jašinskienė E; Traberg R Eur J Med Genet; 2024 Jun; 69():104938. PubMed ID: 38580081 [TBL] [Abstract][Full Text] [Related]
10. High Bone Turnover in Mice Carrying a Pathogenic Notch2 Mutation Causing Hajdu-Cheney Syndrome. Vollersen N; Hermans-Borgmeyer I; Cornils K; Fehse B; Rolvien T; Triviai I; Jeschke A; Oheim R; Amling M; Schinke T; Yorgan TA J Bone Miner Res; 2018 Jan; 33(1):70-83. PubMed ID: 28856714 [TBL] [Abstract][Full Text] [Related]
11. Hajdu-Cheney syndrome: a case report with review of literature. Palav S; Vernekar J; Pereira S; Desai A J Radiol Case Rep; 2014 Sep; 8(9):1-8. PubMed ID: 25426244 [TBL] [Abstract][Full Text] [Related]
13. Bone Structural Characteristics and Response to Bisphosphonate Treatment in Children With Hajdu-Cheney Syndrome. Sakka S; Gafni RI; Davies JH; Clarke B; Tebben P; Samuels M; Saraff V; Klaushofer K; Fratzl-Zelman N; Roschger P; Rauch F; Högler W J Clin Endocrinol Metab; 2017 Nov; 102(11):4163-4172. PubMed ID: 28938420 [TBL] [Abstract][Full Text] [Related]
14. Two-year cyclic infusion of pamidronate improves bone mass density and eliminates risk of fractures in a girl with osteoporosis due to Hajdu-Cheney syndrome. Galli-Tsinopoulou A; Kyrgios I; Giza S; Giannopoulou EZ; Maggana I; Laliotis N Minerva Endocrinol; 2012 Sep; 37(3):283-9. PubMed ID: 22766895 [TBL] [Abstract][Full Text] [Related]
15. Orofacial characteristics in a child with Hajdu-Cheney syndrome. Saji S; Devi K P; Morankar R; Tewari N; Mathur VP; Bansal K Spec Care Dentist; 2024; 44(2):428-433. PubMed ID: 37227705 [TBL] [Abstract][Full Text] [Related]